| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |